ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO0023

Predictors of Recovery of Kidney Function Following AKI During Hospitalization for COVID-19

Session Information

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)

Authors

  • Allam, Sahitya, University of Maryland Medical System, Baltimore, Maryland, United States
  • Wisner, Bennett W., University of Virginia School of Medicine, Charlottesville, Virginia, United States
  • Ravindran, Abhijit, University of Virginia School of Medicine, Charlottesville, Virginia, United States
  • Kalantari, Kambiz, University of Virginia, Charlottesville, Virginia, United States
Background

Studies have shown that COVID-19 hospitalization is associated with severe AKI. However, determinants of kidney function recovery for these patients are not well studied.

Methods

We conducted a retrospective analysis of patients admitted to our institution from March 2020 to April 2021 with diagnoses of COVID-19 and AKI. Recovery of kidney function was defined as a discharge creatinine less than 0.3 mg/dL above baseline. Data on patients’ demographics, comorbidities, AKI stage, ICU admission, and laboratory values were collected by chart review. Univariate analysis and a multivariate logistic regression model were used to identify factors associated with kidney recovery.

Results

Of 216 patients, the average age was 66.3 years and 56.0% were men. 62% of patients had recovery of kidney function by discharge. Univariate analysis identified congestive heart failure (CHF, p = 0.063), AKI-D (p < 0.001), AKI stage (p < 0.001), ICU admission (p < 0.001), and lower albumin (p = 0.040) as correlates of non-recovery at discharge. In the multivariate logistic regression model [(AUC: 0.732, 95% CI (0.664-0.800)], CHF (p = 0.010), AKI-2 (p = 0.011), AKI-3 (p = 0.001), and ICU admission (p = 0.006) remained associated with non-recovery (Table 1). Follow-up data, at a median of 64 days post-discharge, was available for 61% of the cohort (n = 131). Of these patients, 14% had new recovery after discharge, while 18% had no improvement compared to discharge. At 60 days post-discharge, 8.4% had new CKD. At discharge, 3% of all patients were dialysis dependent. Baseline CKD (p = 0.030) and CHF (p = 0.037) were associated with non-recovery at 60 days post-discharge.

Conclusion

History of CHF, severity of AKI, and ICU admission are predictors of non-recovery of kidney function in patients with COVID-19 and AKI.